Rasna Therapeutics was formed in 2013 by a highly experienced industry team together with field-leading scientists, to focus on developing therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
RASNA Therapeutics
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.rasna.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address420 Lexington Avenue, Suite 2525, NY 10170New YorkUnited States
420 Lexington Avenue, Suite 2525, NY 10170
New York
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/rasna-therapeutics-limited” connections=”true” suffix=””]